JP2022514835A5 - - Google Patents
Info
- Publication number
- JP2022514835A5 JP2022514835A5 JP2021534266A JP2021534266A JP2022514835A5 JP 2022514835 A5 JP2022514835 A5 JP 2022514835A5 JP 2021534266 A JP2021534266 A JP 2021534266A JP 2021534266 A JP2021534266 A JP 2021534266A JP 2022514835 A5 JP2022514835 A5 JP 2022514835A5
- Authority
- JP
- Japan
- Prior art keywords
- cysteine
- insulin
- acid
- composition according
- glutamic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024147410A JP2024178193A (ja) | 2018-12-21 | 2024-08-29 | インスリン及びグルカゴンを含む薬学組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2018-0167798 | 2018-12-21 | ||
| KR20180167798 | 2018-12-21 | ||
| PCT/KR2019/018320 WO2020130751A1 (ko) | 2018-12-21 | 2019-12-23 | 인슐린 및 글루카곤을 포함하는 약학 조성물 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024147410A Division JP2024178193A (ja) | 2018-12-21 | 2024-08-29 | インスリン及びグルカゴンを含む薬学組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022514835A JP2022514835A (ja) | 2022-02-16 |
| JP2022514835A5 true JP2022514835A5 (OSRAM) | 2023-01-06 |
Family
ID=71102651
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534266A Pending JP2022514835A (ja) | 2018-12-21 | 2019-12-23 | インスリン及びグルカゴンを含む薬学組成物 |
| JP2024147410A Pending JP2024178193A (ja) | 2018-12-21 | 2024-08-29 | インスリン及びグルカゴンを含む薬学組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024147410A Pending JP2024178193A (ja) | 2018-12-21 | 2024-08-29 | インスリン及びグルカゴンを含む薬学組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220064248A1 (OSRAM) |
| EP (1) | EP3900734A4 (OSRAM) |
| JP (2) | JP2022514835A (OSRAM) |
| KR (1) | KR20200078414A (OSRAM) |
| CN (1) | CN113365651A (OSRAM) |
| AU (1) | AU2019405389B2 (OSRAM) |
| BR (1) | BR112021011557A2 (OSRAM) |
| CA (1) | CA3124340A1 (OSRAM) |
| MX (1) | MX2021007124A (OSRAM) |
| WO (1) | WO2020130751A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7596268B2 (ja) * | 2018-12-21 | 2024-12-09 | ハンミ ファーマシューティカル カンパニー リミテッド | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに活性を有する三重活性体と、インスリンとを含む薬学組成物 |
| CN116096397A (zh) * | 2020-07-15 | 2023-05-09 | 韩美药品株式会社 | 胰高血糖素衍生物或其缀合物对于肝脏疾病的治疗用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| ATE279947T1 (de) | 1996-03-18 | 2004-11-15 | Univ Texas | Immunglobulinähnliche domäne mit erhöhten halbwertszeiten |
| NZ541365A (en) * | 2002-12-27 | 2009-09-25 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| AR081066A1 (es) * | 2010-04-02 | 2012-06-06 | Hanmi Holdings Co Ltd | Conjugado de insulina donde se usa un fragmento de inmunoglobulina |
| SG192038A1 (en) * | 2011-01-20 | 2013-08-30 | Zealand Pharma As | Combination of acylated glucagon analogues with insulin analogues |
| SG10201907106VA (en) | 2013-02-26 | 2019-09-27 | Hanmi Pharmaceutical Co Ltd | Novel insulin analog and use thereof |
| AR100695A1 (es) * | 2014-05-30 | 2016-10-26 | Hanmi Pharm Ind Co Ltd | Composición para el tratamiento de diabetes mellitus que comprende insulina y un agonista dual glp-1 / glucagón |
| EP3151855B1 (en) | 2014-06-08 | 2021-11-24 | REMD Biotherapeutics, Inc. | Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies |
| CR20170293A (es) | 2014-12-30 | 2017-11-03 | Hanmi Pharm Ind Co Ltd | Derivados de glucagón con estabilidad mejorada |
| TN2017000555A1 (en) * | 2015-06-30 | 2019-04-12 | Hanmi Pharm Ind Co Ltd | Glucagon derivative and a composition comprising a long acting conjugate of the same |
| UY36870A (es) | 2015-08-28 | 2017-03-31 | Hanmi Pharm Ind Co Ltd | Análogos de insulina novedosos |
| EP3341025A4 (en) * | 2015-09-24 | 2019-05-01 | Hanmi Pharm. Co., Ltd. | PROTEIN COMPLEX BY USING A SPECIFIC ROLE OF AN IMMUNOMOBILIN FRAGMENT FOR LINKING |
| TW201718629A (zh) * | 2015-09-25 | 2017-06-01 | 韓美藥品股份有限公司 | 包含多個生理多肽及免疫球蛋白Ｆｃ區之蛋白質接合物 |
| SG11201811697SA (en) * | 2016-06-29 | 2019-01-30 | Hanmi Pharmaceutical Co Ltd | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof |
| AU2018215840A1 (en) * | 2017-02-03 | 2019-08-01 | Hanmi Pharm. Co., Ltd. | Long-Acting Conjugate Of A Physiologically Active Material And Use Thereof |
| ES2944544T3 (es) * | 2017-02-03 | 2023-06-22 | Univ Vanderbilt | Sistemas, composiciones y métodos para el tratamiento de la diabetes |
| GB201710822D0 (en) * | 2017-07-05 | 2017-08-16 | Zealand Pharma As | Methods and medical uses relating to the treatment of hypoglycaemia |
-
2019
- 2019-12-23 AU AU2019405389A patent/AU2019405389B2/en active Active
- 2019-12-23 MX MX2021007124A patent/MX2021007124A/es unknown
- 2019-12-23 CN CN201980090567.3A patent/CN113365651A/zh active Pending
- 2019-12-23 US US17/415,474 patent/US20220064248A1/en active Pending
- 2019-12-23 CA CA3124340A patent/CA3124340A1/en active Pending
- 2019-12-23 JP JP2021534266A patent/JP2022514835A/ja active Pending
- 2019-12-23 EP EP19897547.6A patent/EP3900734A4/en active Pending
- 2019-12-23 WO PCT/KR2019/018320 patent/WO2020130751A1/ko not_active Ceased
- 2019-12-23 BR BR112021011557-9A patent/BR112021011557A2/pt unknown
- 2019-12-23 KR KR1020190173205A patent/KR20200078414A/ko active Pending
-
2024
- 2024-08-29 JP JP2024147410A patent/JP2024178193A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7322105B2 (ja) | 免疫グロブリンＦｃフラグメント結合を用いたタンパク質及びペプチドの溶解度を改善する方法 | |
| JP2018526333A5 (OSRAM) | ||
| JP2019504055A5 (OSRAM) | ||
| CN107106660B (zh) | 长效glp-1/胰高血糖素受体双激动剂对于治疗非酒精性脂肪肝疾病的应用 | |
| TWI648401B (zh) | 生長分化因子１５（ｇｄｆ－１５）構築體 | |
| JP6749845B2 (ja) | インスリン及びｇｌｐ−１／グルカゴン二重アゴニストを含む糖尿病治療用組成物 | |
| JP2019524675A5 (OSRAM) | ||
| BRPI0916326A2 (pt) | complexo polipeptídico compreendendo polímero não-peptidil com três extremidades funcionais | |
| RU2009129953A (ru) | Инсулинотропный комплекс, в котором использован фрагмент иммуноглобулина | |
| JP2022551282A5 (OSRAM) | ||
| EA038524B1 (ru) | Длительно действующий конъюгат тройного агониста рецепторов глюкагона/glp 1/gip | |
| CN107810202A (zh) | 长效胰岛素或胰岛素类似物复合物 | |
| RU2015138536A (ru) | Новый аналог инсулина и его применение | |
| RU2016147505A (ru) | Конъюгат, содержащий оксинтомодулин и фрагмент иммуноглобулина, и его применение | |
| JP2016519569A5 (OSRAM) | ||
| CN108064230A (zh) | 使重组抗体分子单体化的方法 | |
| JP2024178193A (ja) | インスリン及びグルカゴンを含む薬学組成物 | |
| IL293745A (en) | Bifunctional molecules comprising an il-7 variant | |
| JP2024512895A5 (OSRAM) | ||
| RU2021116078A (ru) | Фармацевтическая композиция, содержащая инсулин и глюкагон | |
| IL305549A (en) | Pharmaceutical composition for the prevention or treatment of chronic kidney disease including a glucagon derivative | |
| RU2019131593A (ru) | Комплекс аналога инсулина со сниженной аффинностью к инсулиновому рецептору и его применение | |
| CN114984231B (zh) | 稳定性制剂及其制备方法 | |
| RU2847194C1 (ru) | Жидкая композиция длительно действующего конъюгата тройного агониста глюкагона, GLP-1 И GIP | |
| NZ750267B2 (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof |